<DOC>
	<DOCNO>NCT02586337</DOCNO>
	<brief_summary>The purpose study compare effect safety Anlotinib placebo patient Differentiated Thyroid Cancer .</brief_summary>
	<brief_title>Study Anlotinib Patients With Differentiated Thyroid Cancer ( ALTER01032 )</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>1 . Signed date informed consent 2 . Histological documentation Differentiated Thyroid Cancer , With measurable disease ( use RECIST1.1 ) 3 . ECOG PS:01 , Life expectancy 6 month 4 . Subjects must 131Irefractory / resistant define least one following : Lesions demonstrate iodine uptake radioiodine scan Cumulative activity 131I &gt; 600 mCi 22 gigabequerels ( GBq ) Lesion demonstrate iodine uptake radioiodine scan , progress RECIST 1.1 within 18 month 131I therapy 5. main organ function normal 1 . Prior treatment Anlotinib VEGFRtargeted therapy ( Vandetanib , Cabozantinib , Lenvatinib , Sunitinib , Sorafenib etc . ) 2 . Subjects receive radiotherapy external exposure 131I within 3 month prior first dose study drug plan receive anticancer treatment study 3 . Patients suffer malignancy currently within 5 year , except cured cervical carcinoma situ , nonmelanoma skin cancer superficial bladder cancer [ Ta ( noninvasive carcinoma ) , Tis ( carcinoma situ ) T1 ( carcinoma invasion lamina propria ) ] 4 . CTCAE ( 4.0 ) Grade 1 high nonremission toxicity induce previous treatments，excluding alopecia Grade 2 low neurotoxicity induce oxaliplatin 5 . Patients factor could affect oral medication ( dysphagia etc . ) 6 . Patients pleural effusion ascites , cause respiratory syndrome ( CTCAE Grade 2 high dyspnea [ Grade 2 dyspnea refers Shortness breath small amount activity , affect Instrumental activity daily life ] ) 7 . Patients underwent major surgical treatment，open biopsy significant traumatic injury within 28 day prior assignment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>